Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (181-190 of 241) with videos related to

Pageof 25
Sort By:
Plos Biology|July 12, 2021
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategiesStephen M Kissler, Joseph R Fauver, Christina Mack, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Npj Viruses|November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
The New England Journal of Medicine|December 23, 2021
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated PersonsStephen M Kissler, Joseph R Fauver, Christina Mack, et al.
Nature|October 1, 2010
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligationHugo Mouquet, Johannes F Scheid, Markus J Zoller, et al.
Cell Host & Microbe|March 31, 2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteGabriele Cerutti, Yicheng Guo, Tongqing Zhou, et al.
Nature|September 11, 2023
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvirYinkai Duan, Hao Zhou, Xiang Liu, et al.
Immunity|September 30, 2023
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational lockingLihong Liu, Ryan G Casner, Yicheng Guo, et al.
Pageof 25

Showing results (181-190 of 241) with videos related to

Sort By:
Pageof 25
Plos Biology|July 12, 2021
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategiesStephen M Kissler, Joseph R Fauver, Christina Mack, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Npj Viruses|November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsMichael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
The New England Journal of Medicine|December 23, 2021
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated PersonsStephen M Kissler, Joseph R Fauver, Christina Mack, et al.
Nature|October 1, 2010
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligationHugo Mouquet, Johannes F Scheid, Markus J Zoller, et al.
Cell Host & Microbe|March 31, 2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteGabriele Cerutti, Yicheng Guo, Tongqing Zhou, et al.
Nature|September 11, 2023
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvirYinkai Duan, Hao Zhou, Xiang Liu, et al.
Immunity|September 30, 2023
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational lockingLihong Liu, Ryan G Casner, Yicheng Guo, et al.
Pageof 25